Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Haoxi Health Technology Limited Class A ( (HAO) ) has provided an update.
On March 6, 2026, Haoxi Health Technology Limited announced that director Jianbing Zhang resigned from the board for personal reasons, with the company stating his departure did not stem from any disagreement over its operations, policies, or practices. The move underscores a routine governance transition rather than a signal of internal conflict, aiming to reassure investors about board stability.
On the same day, the board appointed 40-year-old executive Chuanjie Hu as an independent director, also naming him chairman of the nominating and corporate governance committee and member of both the compensation and audit committees. Hu’s background in business management and corporate operations, particularly in cultural business development and at a multinational food and beverage group, is expected to strengthen Haoxi Health’s governance structure and support its adherence to Nasdaq and U.S. regulatory requirements.
The most recent analyst rating on (HAO) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Haoxi Health Technology Limited Class A stock, see the HAO Stock Forecast page.
Spark’s Take on HAO Stock
According to Spark, TipRanks’ AI Analyst, HAO is a Neutral.
The overall score reflects a combination of strong valuation, with the stock appearing undervalued, and moderate financial performance, highlighted by revenue growth but hampered by cash flow issues. Technical analysis indicates a lack of strong momentum, contributing to the overall risk profile.
To see Spark’s full report on HAO stock, click here.
More about Haoxi Health Technology Limited Class A
Haoxi Health Technology Limited is a Cayman Islands-incorporated company based in Beijing, China, and listed on Nasdaq. The company operates in the health technology sector, though this filing focuses on its corporate governance rather than specific products or services, indicating an emphasis on maintaining compliance with U.S. listing standards.
Average Trading Volume: 28,628
Technical Sentiment Signal: Sell
Current Market Cap: $65.39M
For detailed information about HAO stock, go to TipRanks’ Stock Analysis page.